Nisa Investment Advisors’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$514K Buy
14,285
+6,200
+77% +$223K ﹤0.01% 992
2025
Q1
$319K Sell
8,085
-27
-0.3% -$1.07K ﹤0.01% 1115
2024
Q4
$244K Buy
8,112
+2,803
+53% +$84.4K ﹤0.01% 1235
2024
Q3
$124K Sell
5,309
-110
-2% -$2.57K ﹤0.01% 1389
2024
Q2
$96.4K Buy
5,419
+103
+2% +$1.83K ﹤0.01% 1486
2024
Q1
$80.9K Buy
5,316
+136
+3% +$2.07K ﹤0.01% 1533
2023
Q4
$88.5K Sell
5,180
-45,100
-90% -$770K ﹤0.01% 1470
2023
Q3
$420K Sell
50,280
-35,800
-42% -$299K ﹤0.01% 1113
2023
Q2
$2.14M Sell
86,080
-20,200
-19% -$502K 0.02% 658
2023
Q1
$1.6M Buy
106,280
+30,760
+41% +$463K 0.01% 721
2022
Q4
$893K Buy
75,520
+65,300
+639% +$772K 0.01% 942
2022
Q3
$59K Buy
10,220
+8,969
+717% +$51.8K ﹤0.01% 1686
2022
Q2
$5K Sell
1,251
-74,400
-98% -$297K ﹤0.01% 2274
2022
Q1
$719K Buy
75,651
+56,900
+303% +$541K 0.01% 969
2021
Q4
$217K Sell
18,751
-7,966
-30% -$92.2K ﹤0.01% 1244
2021
Q3
$889 Buy
26,717
+62
+0.2% +$2 0.01% 951
2021
Q2
$1.03K Buy
26,655
+300
+1% +$12 0.01% 927
2021
Q1
$1.27K Sell
26,355
-215
-0.8% -$10 0.01% 867
2020
Q4
$1.38M Buy
26,570
+5,520
+26% +$287K 0.01% 803
2020
Q3
$563K Buy
21,050
+2,700
+15% +$72.2K ﹤0.01% 1010
2020
Q2
$357K Hold
18,350
﹤0.01% 1138
2020
Q1
$181K Sell
18,350
-75
-0.4% -$740 ﹤0.01% 1217
2019
Q4
$205K Hold
18,425
﹤0.01% 1320
2019
Q3
$103K Hold
18,425
﹤0.01% 1453
2019
Q2
$159K Hold
18,425
﹤0.01% 1356
2019
Q1
$148K Hold
18,425
﹤0.01% 1363
2018
Q4
$76K Buy
18,425
+17,500
+1,892% +$72.2K ﹤0.01% 1403
2018
Q3
$5K Hold
925
﹤0.01% 1873
2018
Q2
$12K Buy
925
+400
+76% +$5.19K ﹤0.01% 1681
2018
Q1
$7K Sell
525
-675
-56% -$9K ﹤0.01% 1742
2017
Q4
$10K Buy
1,200
+200
+20% +$1.67K ﹤0.01% 1742
2017
Q3
$12K Hold
1,000
﹤0.01% 1701
2017
Q2
$10K Buy
1,000
+400
+67% +$4K ﹤0.01% 1723
2017
Q1
$7K Buy
+600
New +$7K ﹤0.01% 1765